Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼ºº°¿¡ µû¸¥ ¸»ÃÊ opioidÀÇ ÅëÁõÁ¶Àý

Sex Differences in the Pain Control by the Peripheral Opioid

´ëÇѱ¸°­³»°úÇÐȸÁö 2013³â 38±Ç 4È£ p.339 ~ 356
¹è¼ºÁ¦, ±è¿Ï¼ö, °­¼ö°æ, ¾î±Ô½Ä, È«ÁøÇ¥, Àü¾çÇö,
¼Ò¼Ó »ó¼¼Á¤º¸
¹è¼ºÁ¦ ( Bae Sung-Jae ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ¾È¸éÅëÁõ±¸°­³»°úÇб³½Ç
±è¿Ï¼ö ( Kim Wan-Su ) - ¿ø±¤´ëÇб³ Ä¡°ú´ëÇÐ Ä¡ÁÖ°úÇб³½Ç
°­¼ö°æ ( Kang Soo-Kyung ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ¾È¸éÅëÁõ±¸°­³»°úÇб³½Ç
¾î±Ô½Ä ( Auh Q-Schick ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ¾È¸éÅëÁõ±¸°­³»°úÇб³½Ç
È«ÁøÇ¥ ( Hong Jung-Pyo ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ¾È¸éÅëÁõ±¸°­³»°úÇб³½Ç
Àü¾çÇö ( Chun Yang-Hyun ) - °æÈñ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ¾È¸éÅëÁõ±¸°­³»°úÇб³½Ç

Abstract

ÀÌ ¿¬±¸¿¡¼­´Â ¸»ÃÊ opioid ¼ö¿ëü¸¦ ÀÌ¿ëÇÑ ÀúÀÛ±Ù ÅëÁõ Á¶Àý ½Ã ¼ºº° È¿°úÀÇ Â÷À̸¦ È®ÀÎÇÏ°íÀÚ RDC/TMD·Î Áø´ÜµÈ Áö¿øÀÚ ³²¼º 20¸í, ¿©¼º 20¸íÀ» saline Áֻ籺, lidocaine Áֻ籺, morphine 1.5 mg Áֻ籺, morphine 3 mg Áֻ籺 °¢°¢ 5¸í¾¿ ¹èÁ¤ÇÏ¿´´Ù.
ÅëÁõºÎÀ§¿¡ ÁÖ»ç Àü, ÁÖ»ç ÈÄ 1½Ã°£, 24½Ã°£, 48½Ã°£¿¡ °¢°¢ ÁÖ°üÀûÀÎ ÅëÁõ Æò°¡ÀÎ ½Ã°¢À¯ÃßôµµÆò°¡, ¸Æ±æÅëÁõ¼³¹®ÁöÆò°¡, ÅëÁõºÎÀ§Ç¥½ÃÆò°¡ ±×¸®°í °´°üÀûÀÎ ÅëÁõ Æò°¡ÀÎ ¾Ð·ÂÅëÁõ¿ªÄ¡Æò°¡¿Í ¾Ð·ÂÅëÁõÇÑ°èÆò°¡¸¦ ½Ç½ÃÇÏ¿´´Ù.
°Ë»ç ÈÄ Æò°¡µÈ ÀڷḦ Åë°è ó¸®ÇÏ¿© ´ÙÀ½°ú °°Àº °á°ú¸¦ ¾ò¾ú´Ù.
1. ½Ã°¢À¯ÃßôµµÆò°¡¿¡¼­´Â ³²³à ¸ðµÎ°¡ morphine 3 mg±º¿¡¼­ Åë°èÇÐÀûÀ¸·Î À¯ÀǼº ÀÖ´Â È¿°ú°¡ ÀÖ¾ú´Ù. (male: p<0.05, female: p<0.05)
2. ¸Æ±æÅëÁõ¼³¹®Áö Æò°¡¿¡¼­´Â ³²³à ¸ðµÎ°¡ morphine 1.5 mg±º º¸´Ù morphine 3 mg±º¿¡¼­ ´õ Åë°èÇÐÀûÀ¸·Î À¯ÀǼº ÀÖ´Â È¿°ú°¡ ÀÖ¾ú´Ù. (male: p<0.001, female: p<0.01)
3. ÅëÁõºÎÀ§Ç¥½ÃÆò°¡¿Í ¾Ð·ÂÅëÁõ¿ªÄ¡Æò°¡¿¡¼­´Â ³²¼ºÀÌ morphine 3 mg±º¿¡¼­ Åë°èÇÐÀûÀ¸·Î À¯ÀǼº ÀÖ´Â È¿°ú°¡ ÀÖ¾ú´Ù. (PD: p<0.001, PPT: p<0.05)
ÀÌ»óÀÇ ¿¬±¸ °á°ú·Î ÀúÀÛ±Ù ÅëÁõÀ» Á¶ÀýÇϱâ À§Çؼ­ morphine 3 mgÀ» ÅëÁõºÎÀ§¿¡ ÁÖ»çÇÑ °æ¿ì °´°üÀûÀÎ ÅëÁõ Æò°¡¿¡¼­ ¿©¼º ȯÀÚº¸´Ù ³²¼º ȯÀÚ¿¡°Ô ´õ È¿°ú°¡ ÀÖ´Ù´Â °ÍÀ» ¾Ë ¼ö ÀÖ¾úÀ¸¸ç, ¾ÕÀ¸·Î ½Ã°£¿¡ µû¸¥ ±×¸®°í ¿ë·®¿¡ µû¸¥ ³²³à Ä¡·áÈ¿°úÀÇ Â÷ÀÌ¿¡ °üÇÑ ¿¬±¸°¡ ´õ ÇÊ¿ä ÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù.

This study was designed to evaluate the sex differences in the pain control effect by morphine injection to masticatory muscle pain patients. Patients with masticatory muscle pain visited the Department of Oral Medicine, Kyung Hee University Dental Hospital were recruited to this study and diagnosed by RDC/TMD.
Experimental group were divided into four group each from male (n=20) and female (n=20); saline injection group (n=5), lidocaine injection group (n=5), morphine 1.5 mg injection group (n=5) and morphine 3 mg injection group (n=5).
Evaluation list was the subjective pain evaluation(visual analogue scale, Mc Gill pain questionnaire, pain drawing) and the objective pain evaluation(pressure pain threshold, pressure pain tolerance) and evaluation time was injection before, after 1 hour, 24 hour, 48 hour and then it was analyzed statistically.
The results were as follows :
1. The male and female were significantly different statistically morphine 3 mg group in visual analogue scale evaluation. (male: p<0.05, female: p<0.05)
2. The male and female were more significantly different statistically morphine 3 mg group than morphine 1.5 mg group in McGill pain questionnaire evaluation. (male: p<0.001, female: p<0.01)
3. The male were significantly different statistically morphine 3 mg group in pain drawing evaluation and pressure pain threshold evaluation. (PD: p<0.001, PPT: p<0.05)
Therefore, it was revealed that the morphine 3 mg injection for masticatory muscle pain was effective to pain control male patients and more effect than female patients in the objective pain evaluation.

Å°¿öµå

¸ôÇÉ È²»ê¿°; ¼ºº° Â÷ÀÌ; ÀúÀÛ±Ù ÅëÁõ; ÃøµÎÇϾÇÀå¾Ö
Morphine sulfate; Masticatory Muscle Pain; Sex Differences; Temporomandibular Disorders

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI